Leaving No Country Behind: Africa’s Pathbreaking Collective Action on Vaccines

This article originally appeared on World Bank Blogs. Below is an excerpt. 

As the health systems of countries across Africa are put under increasing pressure by new waves of COVID-19, there is an urgent need to step up vaccination efforts.  Accelerating equitable access to vaccines is essential for economic recovery and saving lives in Africa.

Achieving the African Union’s targets of getting 40% of the population vaccinated by the end of this year and 60% by the middle of next year will be a great challenge because vaccination rates in Africa remain low. 

While the World Bank is doing its part – already approving 30 operations for vaccine financing and deployment in Africa totaling $2.7 billion – with 11 more on the way – much more is needed.

And that is why we welcome the partnership with the African Union’s Africa Vaccine Acquisition Task Team (AVATT) – an initiative of the African Union Commission, the Africa Centers for Disease Control and Prevention (CDC), Afreximbank, the AU Special Envoys for COVID-19, and UNECA – to convene all relevant players in one virtual room to discuss the roadblocks to vaccine access.

Last week, AVATT, together with the World Bank, held its second coordination meeting with 35 Ministers of Finance and Health from across Africa to identify the myriad of challenges, both in acquisition and deployment of vaccines, that countries on the continent are facing to get jabs in arms and agree upon practical solutions.

These meetings build an intensive effort with our partners to reach a vaccine financing arrangement, aimed at vaccinating over 400m people. In this context each regional and multilateral institution plays a critical role.

There are considerable benefits for countries in taking the regional route towards vaccine procurement—not only does this take everyone along, but it also achieves value for money and is more efficient than each country going alone and negotiating bilaterally with suppliers.

Read the full article here

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More

📣 Lessons from Moldova on the Use of Pharmacists to Increase Demand for COVID-19 Vaccinations

When the COVID-19 vaccines first launched in Moldova, vaccine confidence across the country was low, particularly among target populations. To combat this, Moldova launched a national campaign using pharmacists to increase awareness, confidence, and coverage of the vaccines. Linked recently sat down with Oxana Constantinova, Doctor Epidemiologist, Center for Public Health, Moldova, to understand the … Read More